Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Oct;12(4):537–539. doi: 10.1128/aac.12.4.537

Factors Involved in Beta-Lactam Antibiotic Resistance in Pseudomonas aeruginosa

Hitoshi Ohmori 1, Akiko Azuma 1, Yoji Suzuki 1, Yoshinobu Hashimoto 1
PMCID: PMC429961  PMID: 411418

Abstract

A temperature-sensitive mutant, strain SS, which is assumed to be devoid of β-lactamase activity and deficient in a permeability barrier to antibiotics, was isolated from a β-lactamase-less mutant, strain L-2, derived from Pseudomonas aeruginosa IFO 3080. By comparing the β-lactam antibiotic susceptibility between strains IFO 3080, L-2, and SS, the involvement of both β-lactamase and a permeability barrier in determining the β-lactam antibiotic resistance was estimated.

Full text

PDF
537

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burman L. G., Nordström K., Bloom G. D. Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol. 1972 Dec;112(3):1364–1374. doi: 10.1128/jb.112.3.1364-1374.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Flett F., Curtis N. A., Richmond M. H. Mutant of Pseudomonas aeruginosa 18S that synthesizes type Id beta-lactamase constitutively. J Bacteriol. 1976 Sep;127(3):1585–1586. doi: 10.1128/jb.127.3.1585-1586.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. LEIVE L. A NONSPECIFIC INCREASE IN PERMEABILITY IN ESCHERICHIA COLI PRODUCED BY EDTA. Proc Natl Acad Sci U S A. 1965 Apr;53:745–750. doi: 10.1073/pnas.53.4.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ohmori H., Azuma A., Suzuki Y., Hashimoto Y. Isolation and properties of beta-lactamase-less mutants from clinically important gram-negative bacteria. J Antibiot (Tokyo) 1977 Mar;30(3):267–269. doi: 10.7164/antibiotics.30.267. [DOI] [PubMed] [Google Scholar]
  5. Richmond M. H., Clark D. C., Wotton S. Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains. Antimicrob Agents Chemother. 1976 Aug;10(2):215–218. doi: 10.1128/aac.10.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Richmond M. H., Sykes R. B. The beta-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol. 1973;9:31–88. doi: 10.1016/s0065-2911(08)60376-8. [DOI] [PubMed] [Google Scholar]
  7. Sykes R. B. Resistance of Pseudomonas aeruginosa to antimicrobial drugs. Prog Med Chem. 1975;12:333–393. doi: 10.1016/s0079-6468(08)70180-2. [DOI] [PubMed] [Google Scholar]
  8. Tamaki S., Sato T., Matsuhashi M. Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12. J Bacteriol. 1971 Mar;105(3):968–975. doi: 10.1128/jb.105.3.968-975.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES